Collaborative Arrangement, Shares Available For Exchange

No definition available.

Name:	dtil_CollaborativeArrangementSharesAvailableForExchange
Namespace Prefix:	dtil_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Contract With Customer, Liability, Revenue Recognized As Transaction Price

+ References

No definition available.

+ Details

Name:	dtil_ContractWithCustomerLiabilityRevenueRecognizedAsTransactionPrice
Namespace Prefix:	dtil_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Contract with Customer, Liability, Revenue Recognized Upon Issuance of Shares

+ References

No definition available.

+ Details

Name:	dtil_ContractWithCustomerLiabilityRevenueRecognizedUponIssuanceOfShares
Namespace Prefix:	dtil_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Percentage of premium over the volume-weighted-average-price of the company’s common stock.

+ References

No definition available.

+ Details

Name:	dtil_PercentageOfPremiumOverVolumeWeightedAveragePriceOfCompanysCommonStock
Namespace Prefix:	dtil_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Revenue, Remaining Performance Obligation, Variable Consideration, Additional Milestone, Amount

+ References

No definition available.

+ Details

Name:	dtil_RevenueRemainingPerformanceObligationVariableConsiderationAdditionalMilestoneAmount
Namespace Prefix:	dtil_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Stock Issued, Price Per Share, Number Of Trading Days Prior To Agreement

+ References

No definition available.

+ Details

Name:	dtil_StockIssuedPricePerShareNumberOfTradingDaysPriorToAgreement
Namespace Prefix:	dtil_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-11

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479837/606-10-45-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-8

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479837/606-10-45-2

+ Details

Name:	us-gaap_ContractWithCustomerLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-8

+ Details

Name:	us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(3)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 321
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479536/321-10-50-4

+ Details

Name:	us-gaap_EquitySecuritiesFvNiGainLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	srt_CounterpartyNameAxis=dtil_TGLicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=us-gaap_LicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dtil_PaymentTrancheAxis=dtil_PaymentTrancheOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dtil_PaymentTrancheAxis=dtil_PaymentTrancheTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=dtil_NovartisPharmaAGMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=dtil_DiscoveryAndDevelopmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=dtil_IECUREMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=dtil_DevelopmentAndLicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=dtil_AgricultureIndustryCollaborationPartnerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=dtil_ResearchAndLicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

COLLABORATION AND LICENSE AGREEMENTS (Details) - USD ($)				3 Months Ended
	Mar. 12, 2026	Jan. 06, 2025	Feb. 05, 2024	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Jan. 07, 2024
Collaboration and License Agreements [Line items]
Decrease in fair value of equity				$ 2,951,000	$ (49,000)
TG License \| License
Collaboration and License Agreements [Line items]
Collaborative arrangement, upfront payments and liabilities		$ 2,500,000					$ 10,000,000.0
Sale of stock, number of shares issued in transaction (in shares)		220,712	97,360
Percentage of premium over the volume-weighted-average-price of the company’s common stock (as a percent)		100.00%	100.00%
Number of trading days prior to agreement to determine price per share		30 days	30 days
Sale of stock, price per share (in USD per shares)	$ 11.1660	$ 11.33
Revenue recognized	$ 7,500,000			6,800,000	0
Additional milestone							$ 288,600,000
Contract with customer, liability, revenue recognized upon issuance of shares				700,000
Contract with customer, liability, revenue recognized as transaction price				6,800,000
TG License \| License \| Payment Tranche One
Collaboration and License Agreements [Line items]
Collaborative arrangement, upfront payments and liabilities			$ 5,250,000
Revenue recognized	5,250,000
TG License \| License \| Payment Tranche Two
Collaboration and License Agreements [Line items]
Collaborative arrangement, upfront payments and liabilities			$ 2,250,000
Revenue recognized	$ 2,250,000
Shares available for exchange (in shares)	201,504
Novartis Pharma AG \| Discovery and Development
Collaboration and License Agreements [Line items]
Collaborative arrangement, upfront payments and liabilities				0		$ 0
Revenue recognized				0	100,000
iECURE \| Development and License
Collaboration and License Agreements [Line items]
Decrease in fair value of equity				0	$ 0
Agriculture Industry Collaboration Partner \| Research and License
Collaboration and License Agreements [Line items]
Revenue recognized				$ 4,000,000.0